Article Versions Notes

Dorst DN, Boss M, Rijpkema M, Walgreen B, Helsen MMA, Bos DL, van Bloois L, Storm G, Brom M, Laverman P, et al. Photodynamic Therapy Targeting Macrophages Using IRDye700DX-Liposomes Decreases Experimental Arthritis Development. Pharmaceutics. 2021; 13(11):1868. https://doi.org/10.3390/pharmaceutics13111868

Dorst, Daphne N., Marti Boss, Mark Rijpkema, Birgitte Walgreen, Monique M. A. Helsen, Desirée L. Bos, Louis van Bloois, Gerrit Storm, Maarten Brom, Peter Laverman, and et al. 2021. "Photodynamic Therapy Targeting Macrophages Using IRDye700DX-Liposomes Decreases Experimental Arthritis Development" Pharmaceutics 13, no. 11: 1868. https://doi.org/10.3390/pharmaceutics13111868

Dorst, D. N., Boss, M., Rijpkema, M., Walgreen, B., Helsen, M. M. A., Bos, D. L., van Bloois, L., Storm, G., Brom, M., Laverman, P., van der Kraan, P. M., Buitinga, M., Koenders, M. I., & Gotthardt, M. (2021). Photodynamic Therapy Targeting Macrophages Using IRDye700DX-Liposomes Decreases Experimental Arthritis Development. Pharmaceutics, 13(11), 1868. https://doi.org/10.3390/pharmaceutics13111868